Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
10/2012
10/16/2012US8288345 Treating stroke and other diseases without inhibiting N-type calcium channels
10/16/2012US8288344 Glass particles in aqueous carrier mixture containing glycerol and polyoxyethylene glycol
10/16/2012US8288338 Exendin and exendin agonists for eating disorders
10/16/2012US8288337 Compositions and methods relating to elutable carbohydrate-binding proteins
10/16/2012US8288334 Peptides for wound healing
10/16/2012US8288140 Polypeptides having cellulolytic enhancing activity and nucleic acids encoding same
10/16/2012US8288130 Polypeptide cleavage process
10/16/2012US8288125 Intergenic regions as insertion sites in the genome of modified vaccinia virus Ankara (MVA)
10/16/2012US8288107 Incorporating polynucleotides encoding fusion proteins comprising CFTR peptide and DNA binding domain of transcriptional activator that binds to site on detectable gene into host cell ; gene expressing; drug screening, high throughput assay; enhances dimerization of CFTR protein; cystic fibrosis
10/16/2012US8288096 Diagnostic method for epilepsy
10/16/2012US8287884 Staphylococcus aureus proteins and nucleic acids
10/16/2012US8287881 Synthetic gagpol genes and their uses
10/16/2012US8287878 Synergistic attenuation of vesicular stomatitis virus, vectors thereof and immunogenic compositions thereof
10/16/2012US8287875 Nucleic acids encoding a house dust mite allergen, Der p III, and uses therefor
10/16/2012US8287874 Soluble lymphotoxin-beta receptors and anti-lymphotoxin receptor and ligand antibodies as therapeutic agents for the treatment of immunological diseases
10/16/2012US8287873 Vascular endothelial cell growth factor antagonists and uses thereof
10/16/2012US8287868 bone morphogenic proteins; transforming growth factors; fusion proteins; drug screening; cardiovascular disorders
10/16/2012US8287866 Methods of treating IL-TIF associated inflammatory or immune diseases using antibodies against soluble zcytor 11 cytokine receptors
10/16/2012US8287862 Multidrug resistance-associated polypeptide
10/16/2012US8287859 Methods of reducing toxicity and effects of cocaine by administering a butyrylcholinesterase (BChE)-albumin fusion protein
10/16/2012US8287852 Treatment of viral diseases with recombinant interferon α
10/16/2012US8287850 Conjugates of hydroxyalkyl starch and a protein, prepared by reductive amination
10/16/2012US8287845 Hair-binding peptides
10/16/2012CA2634992C Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
10/16/2012CA2533753C Drug for cancer therapy
10/16/2012CA2530756C Methods for obtaining molecules with reduced immunogenicity
10/16/2012CA2525994C Silk biomaterials and methods of use thereof
10/16/2012CA2516028C Conjugates comprising a cancer targeting molecule linked to a liver-expressed chemokine
10/16/2012CA2498465C Generation of plants with improved pathogen resistance
10/16/2012CA2480696C Peptide epitopes common to antigens of the same multigene family
10/16/2012CA2469492C Diagnostic methods for protein profiling
10/16/2012CA2457804C Transcutaneous immunization against papillomavirus with papillomavirus virus-like particles
10/16/2012CA2453202C Peptides which modulate blood coagulation and methods of use thereof
10/16/2012CA2451847C A novel engineered superantigen for human therapy
10/16/2012CA2443069C Synthesis and use of glycodendrimer reagents
10/16/2012CA2412498C Non-human animal models of tolerance to hepatitis c virus immunogenes
10/16/2012CA2404340C Methods of blocking tissue destruction by autoreactive t cells
10/16/2012CA2363911C Methods for altering organ mass, controlling fertility and enhancing asexual reproduction in plants
10/16/2012CA2357758C Dna encoding canine von willebrand factor and methods of use
10/16/2012CA2356257C Insulin-like growth factor (igf) i mutant variants
10/16/2012CA2223427C Collagen-based delivery matrix
10/16/2012CA2132873C Peptides useful for inducing tolerance
10/11/2012WO2012139112A1 Ubiquitin fusions for improving the efficacy of cytosolic acting targeted toxins
10/11/2012WO2012139097A2 Method of inducing neutralizing antibodies to human immunodeficiency virus
10/11/2012WO2012139046A2 Signal amplification methods for the imaging of protein synthesis and neurotransmitter transport
10/11/2012WO2012139002A2 Anti-tumor antibody-tumor suppressor fusion protein compositions and methods of use for the treatment of cancer
10/11/2012WO2012138977A1 Structural based design of il-17 dominant negative mutants
10/11/2012WO2012138941A1 Compositions comprising glucagon analogs and methods of making and using the same
10/11/2012WO2012138703A1 Axmi115 variant insecticidal gene and methods for its use
10/11/2012WO2012138475A1 Anti-epidermal growth factor receptor variant iii chimeric antigen receptors and use of same for the treatment of cancer
10/11/2012WO2012138470A2 Optimized oligonucleotides and methods of using same for the detection, isolation, amplification, quantitation, monitoring, screening, and sequencing of group b streptococcus
10/11/2012WO2012138429A1 Molecularly imprinted polymers having affinity for natriuretic peptides
10/11/2012WO2012138251A1 Octapeptide, radiopharmaceutical agent based thereon and method for diagnosing tumors
10/11/2012WO2012137970A1 Modified laminin and use thereof
10/11/2012WO2012137896A1 Method for producing sheet-like pancreatic islet
10/11/2012WO2012137502A1 Diagnosis method or prognosis prediction method for dementia or alzheimer's disease using alcadein peptide cleavage product
10/11/2012WO2012137479A1 Peptide which can induce antibody capable of recognizing stereostructure of hiv
10/11/2012WO2012137147A1 Compositions
10/11/2012WO2012137036A1 Cell penetrating peptides for intracellular delivery of molecules
10/11/2012WO2012137012A1 Crystal structure of an a2a adenosine receptor
10/11/2012WO2012136909A2 Thixotropic α-lactalbumin hydrogels, method for preparing same and uses thereof
10/11/2012WO2012136831A1 Non-replicative virions of human immunodeficiency virus and therapeutic applications thereof
10/11/2012WO2012136819A1 Therapeutic and prophylactic methods, uses and compositions comprising anexin a5
10/11/2012WO2012136653A1 Proteins and nucleic acids useful in vaccines targeting staphylococcus aureus
10/11/2012WO2012136506A2 Microorganism and processes for the fermentative production of an organo-chemical compound
10/11/2012WO2012136476A1 Method of activating a target gene in a cell
10/11/2012WO2012136231A1 Interleukin 15 as selectable marker for gene transfer in lymphocytes
10/11/2012WO2012136172A1 Method for producing injectable formulations of blood-derived protein materials, and materials obtained using said method
10/11/2012WO2012136129A1 Application of ossro1c gene in controlling rice drought resistance
10/11/2012WO2012135959A1 Protease cleavage site peptides as an hiv vaccine
10/11/2012WO2012118444A9 Novel compounds with photoluminescnce properties and applications thereof
10/11/2012WO2012118349A9 Differentiation and proliferation method for natural killer cells from cd14-positive monocytes
10/11/2012WO2012112869A3 Targeted cancer therapy using ets transcriptional inhibitors
10/11/2012WO2012103360A3 Wnt compositions and methods of use thereof
10/11/2012WO2012094394A3 Methods and compositions for assessing and treating adrenal diseases and disorders
10/11/2012WO2012085936A3 Recombinant respiratory syncytial virus plasmids and vaccines
10/11/2012WO2012065852A3 Therapeutic gremlin protein
10/11/2012WO2012057465A3 Salt tolerance sygt gene derived from synechocystis, and uses thereof
10/11/2012WO2012007945A8 Isolated polynucleotides and methods and plants using same for regulating plant acidity
10/11/2012US20120260372 TRANSGENIC PLANTS EXPRESSING MODIFIED Cry3A
10/11/2012US20120260364 Plants and seeds of spring canola variety scv695971
10/11/2012US20120259093 Expression of secreted human alpha-fetoprotein in transgenic animals
10/11/2012US20120258998 Fusion genes in gastrointestinal cancer
10/11/2012US20120258997 New application of 2-pyrrolidone derivatives
10/11/2012US20120258918 Polypeptoid pulmonary surfactants
10/11/2012US20120258917 Peripheral Administration of Proteins Including TGF-beta Superfamily Members for Treatment of Systemic Disorders and Disease
10/11/2012US20120258916 Ophthalmic preparations based on bdnf (brain-derived neurotrophic factor) and their use
10/11/2012US20120258915 Proteolysis Resistant Active VEGF
10/11/2012US20120258910 Novel bacillus thuringiensis insecticidal proteins
10/11/2012US20120258907 Treatment of fungal and/or protist infections
10/11/2012US20120258887 Cc2d2a gene mutations associated with joubert syndrome and diagnostic methods for identifying the same
10/11/2012US20120258872 Prevention, treatment and diagnosis of diseases associated with beta-amyloid formation and/or aggregation
10/11/2012US20120258519 Protein Harvesting
10/11/2012US20120258517 Cytolethal distending toxins and detection of campylobacter bacteria using the same as a target
10/11/2012US20120258515 Cytolytic RTX-Toxin From Gallibacterium Anatis
10/11/2012US20120258514 Kits for analysis of biological samples
10/11/2012US20120258491 Expression of biologically active polypeptides in duckweed
10/11/2012US20120258490 Process for producing dipeptides or dipeptide derivatives
10/11/2012US20120258489 Fungal promoters for expressing a gene in a fungal cell
10/11/2012US20120258465 Mutant apoprotein of photoprotein with low calcium sensitivity
1 ... 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 ... 2916